Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | CRHBP | P24387 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.69 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.69 |
| ▸ | ANPEP | P15144 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CCR1 | P32246 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1995534 | 1.00 | MEN1 (0.69) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL9461939 | 0.87 | CA2 (0.69) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL1158031 | 0.87 | CA2 (0.69) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL1158033 | 0.87 | CA2 (0.69) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| Water SCHEMBL28867161 | 0.85 | CA2 (0.67) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| Lithium SCHEMBL6646645 | 0.85 | CA2 (0.67) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL6646636 | 0.85 | CA2 (0.67) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL2692997 | 0.84 | ALDH1A1 (0.53) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL203318 | 0.84 | ALDH1A1 (0.53) | MEN1ALDH1A1CRHBPKMT2ACRHR2 | |
| SCHEMBL4388416 | 0.84 | MEN1 (0.63) | MEN1ALDH1A1CRHBPKMT2ACRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088804-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2012-01-03 | — | — | US | disclosed |
| US-8088804-B2 | N-hydroxyamide derivatives possessing antibacterial activity | PFIZER INC. (US) | 2012-01-03 | — | — | US | disclosed |
| EP-2338878-A2 | N-hydroxyamide derivatives possessing antibacterial activity | Vicuron Pharmaceuticals, Inc. (US) | 2011-06-29 | — | — | EP | disclosed |
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. | 2010-01-28 | — | — | US | disclosed |
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022605-A1 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | NAAA, HDHD5, HACL2 | MEN1 3364/4885ALDH1A1 343/4885CRHBP 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.